1. Moderna, in unusual move, discloses detailed plan of coronavirus vaccine trial — Lilly and Amgen join forces to scale production of COVID-19 antibody cocktails — Another regulatory hiccup for Sarepta Therapeutics — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Avoid this company

Discussion in 'Phenogen Sciences' started by anonymous, Jul 28, 2015 at 2:45 PM.

  1. anonymous

    anonymous Guest

    The product has potential, the senior management does not. I would be wary of this company.